|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"tsay w"
Showing items 521-530 of 637 (64 Page(s) Totally)
<< < 48 49 50 51 52 53 54 55 56 57 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2015 |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
Huang C.-F.; Tseng M.-H.; Chuang S.-S.; Chen C.-Y.; Lin C.-W.; Liu C.-Y.; Chou W.-C.; Kuo Y.-Y.; Lee M.-C.; Lai Y.-J.; Jhuang J.-Y.; Tang J.-L.; Hou H.-A.; Chen Y.-K.; Tien H.-F.; Chen Y.-C.; Tsay W.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Yao M.; Huang S.-Y.; BOR-SHENG KO; Hsu S.-C.; Wu S.-J. |
| 臺大學術典藏 |
2015 |
TP53 mutations in de novo acute myeloid leukemia patients: Longitudinal follow-ups show the mutation is stable during disease evolution
|
Li C.-C.; Yao M.; Liu C.-W.; Tang J.-L.; Liu M.-C.; Chiang Y.-C.; Tseng M.-H.; Lin L.-I.; Liu C.-Y.; Kuo Y.-Y.; Chou W.-C.; Hou H.-A.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; Chen Y.-C.; HWEI-FANG TIEN |
| 國立臺灣大學 |
2014 |
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
|
Hou, H-A; Lin, C-C; Chou, W-C; Liu, C-Y; Chen, C-Y; Tang, J-L; Lai, Y-J; Tseng, M-H; Huang, C-F; Chiang, Y-C; Lee, F-Y; Kuo, Y-Y; Lee, M-C; Liu, M-C; Liu, C-W; Lin, L-I; Yao, M.; Huang, S-Y; Ko, B-S; Hsu, S-C; Wu, S-J; Tsay, W.; Chen, Y-C; Tien, H-F; 林吉崇; 蔡偉; 李玢玉; 林亮音; 姚明; 陳建源; 陳耀昌; 柯博升; 徐思淳; 田蕙芬; 劉敏枝; 陳宜君; 郭遠燁; 黃聖懿; 吳尚儒; 唐季祿; 周文堅; 侯信安 |
| 國立臺灣大學 |
2014 |
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome
|
Chen, T-C; Hou, H-A; Chou, W-C; Tang, J-L; Kuo, Y-Y; Chen, C-Y; Tseng, M-H; Huang, C-F; Lai, Y-J; Chiang, Y-C; Lee, F-Y; Liu, M-C; Liu, C-W; Liu, C-Y; Yao, M.; Huang, S-Y; Ko, B-S; Hsu, S-C; Wu, S-J; Tsay, W.; Chen, Y-C; Tien, H-F; 蔡偉; 李玢玉; 姚明; 陳建源; 陳耀昌; 柯博升; 徐思淳; 田蕙芬; 劉敏枝; 陳宜君; 郭遠燁; 黃聖懿; 吳尚儒; 唐季祿; 周文堅; 侯信安 |
| 國立臺灣大學 |
2014 |
Clinical Implications of the SETBP1 Mutation in Patients With Primary Myelodysplastic Syndrome and its Stability During Disease Progression
|
Hou, H. A.; Kuo, Y. Y.; Tang, J. L.; Chou, W. W.; Yao, M.; Lai, Y. L.; Lin, C. C.; Chen, C. Y.; Liu, C. Y.; Lee, M. C.; Tseng, M. H.; Huang, C. F.; Chiang, Y. C.; Lee, F. Y.; Liu, M. C.; Liu, C. Y.; Huang, S. Y.; Ko, B. S.; Wu, S. J.; Tsay, W.; Chen, Y. C.; Tien, H. F.; 林吉崇; 蔡偉; 李玢玉; 姚明; 陳建源; 柯博升; 田蕙芬; 陳宜君; 郭遠燁; 黃聖懿; 吳尚儒; 唐季祿 |
| 臺大學術典藏 |
2014 |
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression
|
HWEI-FANG TIEN; Chen Y.-C.; Wu S.-J.; Tsay W.; Huang S.-Y.; Ko B.-S.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Hou H.-A.; Kuo Y.-Y.; Tang J.-L.; Chou W.-C.; Yao M.; Lai Y.-J.; Lin C.-C.; Chen C.-Y.; Liu C.-Y.; Tseng M.-H. |
| 臺大學術典藏 |
2014 |
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
|
HWEI-FANG TIEN; Chou S.-J.; Chou W.-C.; Tsay W.; Chen C.-Y.; Hou H.-A.; Lu H.-Y.; Chen Y.-C.; Wu S.-J.; Tang J.-L.; Lin H.-H.; Yao M.; Huang S.-Y.; Lin C.-W. |
| 臺大學術典藏 |
2014 |
SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution
|
Tseng M.-H.; Chen C.-Y.; Liu C.-Y.; Kuo Y.-Y.; Wu S.-J.; Chou W.-C.; Hou H.-A.; Lin C.-C.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Hsu S.-C.; Ko B.-S.; Tsay W.; Chen Y.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2014 |
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
|
Lee M.-C.; Liu M.-C.; Kuo Y.-Y.; Lee F.-Y.; Huang C.-F.; Chiang Y.-C.; Tseng M.-H.; Lai Y.-J.; Tang J.-L.; Chen C.-Y.; Liu C.-Y.; Chou W.-C.; Lin C.-C.; Hou H.-A.; Liu C.-W.; Lin L.-I.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2014 |
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
|
MING YAO; Lin C.-W.; Lin H.-H.; Huang S.-Y.; Chou S.-J.; Chou W.-C.; Tsay W.; Chen C.-Y.; Hou H.-A.; Chen Y.-C.; Lu H.-Y.; Wu S.-J.; Tang J.-L.; Tien H.-F. |
Showing items 521-530 of 637 (64 Page(s) Totally)
<< < 48 49 50 51 52 53 54 55 56 57 > >>
View [10|25|50] records per page
|
